APOC3 and metabolic dysfunction-associated steatotic liver disease: To test the antioxidant effect on nonalcoholic fatty liver disease (NAFLD), aucubin was tested on 3T3-L1 cells stimulated using apoC-III on mice with tyloxapol-induced NAFLD.